Freedom Foods reports strong first half profit growth

The Freedom Foods Group Ltd (ASX:FNP) share price will be on watch on Friday after revealing strong profit growth in the first half…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Freedom Foods Group Ltd (ASX: FNP) share price will be one to watch on Friday.

This follows the after-hours release of the diversified food company's half year results today.

a woman

How did Freedom Foods perform in the first half?

For the six months ended December 31, Freedom Foods delivered net sales of $299.7 million and operating EBDITA of $32.7 million. This represents an increase of 43.4% and 55.6%, respectively, over the prior corresponding period. The latter was driven partly by the widening of its gross margin from 24.7% to 27.1%.

Management advised that this result reflected increased sales and earnings contributions from its Dairy Beverage, Nutritionals and Plant Beverage business units. This was offset partially by reductions in Cereals & Snacks and Specialty Seafood sales compared to the prior corresponding period.

On the bottom line, Freedom Foods reported an operating net profit after tax increase of 42.1% to $9.1 million and a 45.6% lift in statutory net profit after one-offs and non-cash expenses to $5.4 million.

Net cash from operating activities came in at $15.4 million. However, due to its investment in property, plant and equipment, the company recorded a net decrease in cash of $48.2 million. This left Freedom Foods with a cash balance of $7.2 million at the end of the period.

In light of this, the Freedom Foods board declared a 2.25 cents per share unfranked dividend, which is flat on the prior corresponding period.

Coronavirus update.

The company's managing director and CEO, Rory Macleod, advised that Freedom Foods expects some short-term disruption from the coronavirus outbreak. However, the company remains very positive on its medium term prospects.

He said: "While the Group expects some short-term disruption to China demand over the next few months as internal supply chains in China return to normal operation, the underlying medium-term demand from key customers in this market remains unchanged, with the Group scheduled to start supply to new China based customers from June 2020. Sales to China represent approximately 15% of our net sales value in the current half year."

Outlook.

While no concrete guidance was provided for the full year, Mr Macleod appears confident that its strong growth will continue in the second half.

He advised: "Increasing revenues from the current and expanded capabilities, including ingredients and new consumer applications, are expected to materially positively impact sales and earnings into 2nd half FY 2020 and beyond."

"We expect the Group to deliver higher sales and earnings growth in the second half of FY 2020, reflecting seasonality and further growth across key business activities," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Freedom Foods Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »